Journal of the American Chemical Society
Page 6 of 7
Kummerle, A. E.; Fraga, C. A. Chem. Rev. 2011, 111, 5215-5246. (c)
Scho nherr, H.; Cernak, T. Angew. Chem., Int. Ed. 2013, 52,
12256−12267.
2. Anderson, K. E.; Stamler, D.; Davis, M. D.; Factor, S. A.; Hauser,
R. A.; Isojärvi, J.; Jarskog, L. F.; Jimenez-Shahed, J.; Kumar, R.;
McEvoy, J. P.; Ochudlo, S.; Ondo, W. G.; Fernandez, H. H. The Lancet
Psychiatry 2017, 4, 595−604.
CONCLUSION
̈
1
2
3
4
5
6
7
8
In summary, we reveal an approach based on slow-re-
lease of MeI for the methylation of arylboronates with tri-
methylphosphate. This reagent is inexpensive and non-
toxic, but has not been used previously as a source of a me-
thyl group in coupling chemistry. By this unusual mecha-
nism, the yields for methylation with PO(OMe)3 are higher
than those of the more reactive methyl electrophiles MeOTs
and MeI. Although the mechanism involves a web of on-cy-
cle and off-cycle steps that make the reaction occur in high
yield, it is amenable to large scale and to the late-stage func-
tionalization of pharmaceutical intermediates. The reaction
with 200 mmol of arylboronate occurred the same as reac-
tions on 0.2 mmol, and four medicinally active compounds
were converted selectively into the methyl analogs. The for-
mation of MeI from trimethylphosphate and LiI was rate
limiting, and steps on the catalytic cycle, including the reac-
tion of MeI with the arylcopper species were fast. Overall,
this process shows an approach to using a methylating
agent that does not react directly with the metal center and
is reminiscent of the use of MeOH with HI for rhodium- and
iridium-catalyzed synthesis of acetic acid and acetic anhy-
dride via the generation of MeI.
3. Yan, G.; Borah, A. J.; Wang, L.; Yang, M. Adv. Synth. Catal. 2015,
357, 1333−1350.
4. Hall, D. G. In Boronic Acids: Preparation and Applications in Or-
ganic Synthesis and Medicine, Wiley-VCH: Weinheim. 2005; pp 1
−99.
5. (a) Gooßen, L. J. Appl. Organomet. Chem. 2004, 18, 602−604.
(b) Yang, C. T.; Zhang, Z. Q.; Liu, Y. C.; Liu, L. Angew. Chem. Int. Ed.
2011, 50, 3904−3907.
6. (a) Mkhalid, I. A. I.; Barnard, J. H.; Marder, T. B.; Murphy, J. M.;
Hartwig, J. F. Chem. Rev. 2010, 110, 890−931. (b) Hartwig, J. F. Acc.
Chem. Res. 2012, 45, 864−873. (c) Xu, L.; Wang, G.; Zhang, S.; Wang,
H.; Wang, L.; Liu, L.; Jiao, J.; Li, P. Tetrahedron 2017, 73, 7123−7157.
7. LD50 (oral, rats, mg/kg): MeI (78), MeOTs (341), SO2(OMe)2
(205), PO(OMe)3 (2000).
8. (a) Jones, F. W.; Osborne, G. O.; Sutherland, G. J.; Topsom, R. D.;
Vaughan, J. Chem. Commun. 1966, 18–19. (b) Duclos, M.-C.; Herb-
inski, A.; Mora, A.-S.; Metay, E.; and Lemaire. M. ChemSusChem
2018, 11, 547–551.
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
9. Collins, K. D.; Glorius, F. Nat. Chem. 2013, 5, 591−601.
10. Minisci, F.; Bernardi, R.; Bertini, F.; Galli, R.; Perchinummo, M.
Tetrahedron 1971, 27, 3575−3579.
ASSOCIATED CONTENT
11. (a) Jin, J.; MacMillan, D. W. Nature 2015, 525, 87−90. (b) Liu,
W.; Yang, X.; Zhou, Z.-Z.; Li, C.-J. Chem. 2017, 2, 688−702. (c) Gui, J.;
Zhou, Q.; Pan, C. M.; Yabe, Y.; Burns, A. C.; Collins, M. R.; Ornelas, M.
A.; Ishihara, Y.; Baran, P. S. J. Am. Chem. Soc. 2014, 136, 4853−4856.
12. (a) Giri, R.; Maugel, N.; Li, J. J.; Wang, D. H.; Breazzano, S. P.;
Saunders, L. B.; Yu, J. Q. J. Am. Chem. Soc. 2007, 129, 3510−3511. (b)
Shang, R.; Ilies, L.; Nakamura, E. J. Am. Chem. Soc. 2016, 138,
10132−10135.
13. Sashikanth, S.; Raju, V.; Somaiah, S.; Rao, P. S.; Reddy, K. V.
Synthesis 2013, 45, 621−624.
14. Wang, Y.; Wang, J.; Lin, Y.; Si-Ma, L.-F.; Wang, D.-H.; Chen, L.-
G.; Liu, D.-K. Bioorg. Med. Chem. 2011, 21, 4454−4456.
15. Mondal, J.; Sreejith, S.; Borah, P.; Zhao, Y. ACS Sustainable
Chem. Eng. 2014, 2, 934−941.
Supporting Information. This material is available free of
Experimental details and procedures, spectra for all unknown
compounds (PDF)
AUTHOR INFORMATION
Corresponding Author
*jhartwig@berkeley.edu
ORCID
John F. Hartwig: 0000-0002-4157-468X
Zhi-Tao He: 0000-0003-2375-9557
Haoquan Li: 0000-0002-8636-1979
16. Kourounakis, A. P.; Rekka, E. A.; Kourounakis, P. N. J. Pharm.
Pharmacol. 1997, 49, 938−942.
17. (a) Whittaker, A. M.; Rucker, R. P.; Lalic, G. Org. Lett. 2010,
12, 3216−3218. (b) Ohishi, T.; Nishiura, M.; Hou, Z. Angew. Chem.
Int. Ed. 2008, 47, 5792−5795. (c) Dang, L.; Lin, Z.; Marder, T. B. Or-
ganometallics 2010, 29, 917−927. (d) Gurung, S. K.; Thapa, S.; Kafle,
A.; Dickie, D. A.; Giri, R. Org. Lett. 2014, 16, 1264−1267.
18. Kobayashi, Y.; Ikoma, A. Synlett 2014, 25, 1150−1154.
19. Procter, R. J.; Dunsford, J. J.; Rushworth, P. J.; Hulcoop, D. G.;
Layfield, R. A.; Ingleson, M. J. Chem.– Eur. J., 2017, 23, 15889–
15893.
20. The reaction of o-tol-Bpin(OtBu) generated in situ with an
equimolar amount of MeI at 40 °C led to 38% conversion of the o-
tol-Bpin(OtBu) after 1 h, which is significantly slower than the re-
action of ArCu with MeI (half life < 2 minutes).
Author Contributions
§Z.-T. H. and H. L contributed equally.
Notes
The authors declare no competing financial interests.
ACKNOWLEDGMENT
We thank Dow AgroSciences for support of this work and the
DAAD for a Postdoc Fellowship to A.M.H.
REFERENCES
1. (a) Bazzini, P.; Wermuth, C. G., Chapter 20 - Substituent
Groups. In The Practice of Medicinal Chemistry (Third Edition), Ac-
ademic Press: New York, 2008; pp 429−463. (b) Barreiro, E. J.;
ACS Paragon Plus Environment